--- title: "Popular pre-market trades in US stocks: Turn Therapeutics pre-market down 7.11%; Credo Tech pre-market down 4.01%" type: "News" locale: "en" url: "https://longbridge.com/en/news/292057831.md" description: "Turn Therapeutics pre-market down 7.11%; Credo Tech pre-market down 4.01%; Edible Garden AG pre-market up 62.49%; iOthree pre-market up 52.79%; Battalion Oil pre-market up 28.66%" datetime: "2026-07-08T11:02:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292057831.md) - [en](https://longbridge.com/en/news/292057831.md) - [zh-HK](https://longbridge.com/zh-HK/news/292057831.md) generator: "portal-rs" --- # Popular pre-market trades in US stocks: Turn Therapeutics pre-market down 7.11%; Credo Tech pre-market down 4.01% **Pre-market Hot Trades in US Stocks** Turn Therapeutics is down 7.11% in pre-market trading. Based on recent key news: 1. On July 7, Turn Therapeutics announced that the preliminary results of its Phase II trial for GX-03 in treating atopic dermatitis showed significant efficacy, leading to a 2.9% increase in stock price during after-hours trading. The company plans to share trial data and optimized trial design in a live broadcast. 2. On July 8, Turn Therapeutics stated that its Phase II trial will continue to evaluate patients with a higher inflammatory burden and expand the recruitment scope. The company expects to complete recruitment by the fourth quarter of 2026 and indicated that it has sufficient funds to support operations until the third quarter of 2027. 3. On July 7, GX-03 demonstrated clinically significant efficacy in a broad range of atopic dermatitis patients, prompting the company to expand the Phase II trial to include mild to moderate patients. The biotech sector has been active recently, with noticeable capital inflows. Credo Tech is down 4.01% in pre-market trading. There has been no significant news recently; trading is active with clear capital flows. Considering sector and industry trends, the stock shows notable volatility, and specific reasons need further observation. no\_news **Top Gainers in Pre-market US Stocks** Edible Garden AG is up 62.49% in pre-market trading. Based on recent key news: 1. On July 8, HRT Financial purchased 416,812 shares of Edible Garden AG common stock in the open market, with purchase prices ranging from $0.12 to $0.17 per share. This move reflects investor confidence in the company, driving a significant increase in stock price. 2. On July 8, Edible Garden AG submitted Form 3, showing that HRT Financial LP is a 10% shareholder, directly holding 709,651 shares of common stock. This further bolstered market confidence in the company, promoting stock price growth. 3. There have been no other significant news recently. The market holds an optimistic view of the company, with noticeable capital inflows. iOthree is up 52.79% in pre-market trading. Based on recent key news: 1. On July 7, iOThree Limited released a shareholder letter detailing the latest developments in the company's digital solutions in the maritime sector. This announcement enhanced investor confidence in the company's future growth, leading to a significant increase in stock price. 2. On July 7, iOThree published important documents through the EDGAR system, further clarifying the company's strategic direction and market positioning. This increase in transparency helps to enhance market trust in the company, promoting stock price rise. 3. Recently, there has been an increased demand for maritime digital solutions, and iOThree, as a leading company in this field, benefits from the overall positive trend in the industry, driving stock price growth. Increased demand for maritime digital solutions, industry improvement Battalion Oil, pre-market up 28.66%, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation ### Related Stocks - [TTRX.US](https://longbridge.com/en/quote/TTRX.US.md) - [CRDO.US](https://longbridge.com/en/quote/CRDO.US.md) - [EDBL.US](https://longbridge.com/en/quote/EDBL.US.md) - [IOTR.US](https://longbridge.com/en/quote/IOTR.US.md) - [BATL.US](https://longbridge.com/en/quote/BATL.US.md) ## Related News & Research - [Credo Technology Risk Profile Unchanged: Investors Must Rely on May 2026 Form 10-K Disclosures](https://longbridge.com/en/news/297998236.md) - [Turn Therapeutics says mouse study shows GX-03 cuts dermatitis severity 66%](https://longbridge.com/en/news/296487429.md) - [Turn Therapeutics sells 135,000 shares in private placement for $1.35 million](https://longbridge.com/en/news/296141997.md) - [Turn Therapeutics releases corporate deck outlining GX-03 topical immunomodulator program for atopic dermatitis](https://longbridge.com/en/news/294063417.md) - [7,351 Shares in Credo Technology Group Holding Ltd. $CRDO Bought by SlateStone Wealth LLC](https://longbridge.com/en/news/288928631.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**